NCT06135675View on ClinicalTrials.gov

PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 27, 2020

Primary Completion Date

June 16, 2021

Study Completion Date

June 16, 2021

Conditions
Hyperammonemia
Interventions
DRUG

TNP-2092 capsules

Administration orally.

DRUG

Placebo

Administration orally.

Trial Locations (1)

Unknown

The First Hospital of Jilin University, Changchun

All Listed Sponsors
collaborator

The First Hospital of Jilin University

OTHER

lead

TenNor Therapeutics (Suzhou) Limited

INDUSTRY

NCT06135675 - PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia | Biotech Hunter | Biotech Hunter